This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
1. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;4:641-652.
2. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
3. Heyman A, Fillenbaum G, Mirra SS. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components. Aging Clin Exp Res 1991;2:415-424.
4. Welsh K, Butters N, Hughes JP, Mohs RC, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278-281.
5. Welsh K, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease: use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992;49:448-452.
6. Mirra SS, Heyman A, McKeel DW, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
7. Davis PC, Gray L, Albert M, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III: reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology 1992;42:1676-1680.
8. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-144.
9. Mirra SS, Gearing M, Sumi SM, Crain BJ, Heyman A. The neuropathology assessment of Alzheimer's disease and related dementias: the CERAD experience. In: Coran B, Iqbal K, Nicolini M, et al, eds. Alzheimer's disease: advances in clinical and basic research. John Wiley & Sons Ltd, 1993:207-211.
10. Ballard E, Nash F, Raiford K, Harrell L. Recruitment of black elderly …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
Neuropsychological test performance in African-American* and white patients with Alzheimer's disease